Leukemia Research
Volume 26, Issue 3 , Pages 261-269 , March 2002

Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data

  • Sally L Glaser

      Affiliations

    • Northern California Cancer Center, 32960 Alvarado-Niles Road, Suite 600, Union City, CA 94587, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-510-429-2547; Fax: +1-510-991-4405
    • ,
  • Joe L Hsu

      Affiliations

    • Northern California Cancer Center, 32960 Alvarado-Niles Road, Suite 600, Union City, CA 94587, USA
    • Tufts University School of Medicine, Boston, MA 02111, USA

Received 3 April 2001 ,Accepted 9 July 2001.

References 

  1. Mueller N. Hodgkin's disease. In:  Schottenfeld D,  Fraumeni JF editor. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 1996;p. 893–919
  2. Glaser SL, Jarrett RF. The epidemiology of Hodgkin's disease. Bailliere's Clin. Haematol. 1996;9:401–416
  3. Liang RHS, Yau CC, Muckaden MA, Dinshaw KA, Todd D. Hodgkin's disease in Asia. In:  Mauch PM,  Armitage JO,  Diehl V,  Hoppe RT,  Weiss LM editor. Hodgkin's Disease. Philadelphia, PA: Lippincott Williams & Williams; 1999;p. 771–780
  4. Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. N. Engl. J. Med. 1981;304:135–140
  5. Westergaard T, Melbye M, Pedersen JB, Frisch M, Olsen JH, Andersen PK. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int. J. Cancer. 1997;72:977–981
  6. Percy C, Van Holten V, Muir C. ICD-O. International Classification of Diseases for Oncology. Second ed. Geneva: World Health Organization; 1990;
  7. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. In: SEER Cancer Statistics Review, 1973–1997. Bethesda, MD: National Cancer Institute; 2000;
  8. Perkins CI, Wright WE, Schlag R. In: Cancer Incidence and Mortality in California by Race/Ethnicity, 1988–1994. Sacramento, CA: California Department of Health Services Cancer Surveillance Section; 1997;
  9. World Health Organization. International Classification of Disease, 9th Revision, 1975 Revision. Geneva: World Health Organization, 1977.
  10. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Lyon: International Agency for Research on Cancer; 1997;
  11. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat. Med. 1997;16:791–801
  12. Glaser S, Dorfman R, Clarke C. Expert review of the diagnosis and histologic classification of Hodgkin's disease in a population-based cancer registry: Interobserver reliability and impact on incidence and survival rates. Cancer 2001;92:218–224.
  13. Glaser SL, Clarke CA, Stearns CB, Dorfman RF. Age variation in Hodgkin's disease risk factors in older women: evidence from a population-based case-control study. Leuk Lymph 2001 (in press).
  14. MacMahon B. Epidemiological evidence on the nature of Hodgkin's disease. Cancer. 1957;10:1045–1054
  15. Nishiyama H, Inoue T. Some epidemiological features of Hodgkin's disease in Japan. Gann. 1970;61:197–205
  16. Correa P, O'Conor GT. Geographic pathology of lymphoreticular tumors: summary of survey from the Geographic Pathology Committee of the International Union Against Cancer. J. Natl. Cancer Inst. 1973;51:1609–1617
  17. Kageyama K, Mikata A, Watanabe S. Hodgkin's disease in Japan. GANN Monogr. Cancer Res. 1973;15:239–252
  18. Wakasa H. Hodgkin's disease in Asia, particularly in Japan. Natl. Cancer Inst. Monogr. 1973;36:15–22
  19. Akazaki K, Wakasa H. Frequency of lymphoreticular tumors and leukemias in Japan. J. Natl. Cancer Inst. 1974;52:339–343
  20. Mason T, Fraumeni JF. Hodgkin's disease among Japanese Americans. Lancet. 1974;1:215
  21. Correa P. Hodgkin's disease: international mortality patterns and time trends. World Health Stat. Rep. 1977;30:146–154
  22. Aozasa K, Ueda T, Tamai M, Tsujimura T. Hodgkin's disease in Osaka, Japan (1964–1985). Eur. J. Cancer Clin. Oncol. 1986;22:1117–1119
  23. Yanagihara E, Blaisdell R, Hayashi T, Lukes R. Malignant lymphoma in Hawaii–Japanese: a retrospective morphologic survey. Hematol. Oncol. 1989;7:219–232
  24. Goodman MT, Yoshizawa CN, Kolonel LN. Ethnic patterns of childhood cancer in Hawaii between 1960 and 1984. Cancer. 1989;64:1758–1763
  25. Stiller CA, Parkin DM. International variations in the incidence of childhood lymphomas. Paediatr. Perinatal Epidemiol. 1990;4:303–324
  26. Ajiki W, Hanai A, Tsukuma H, Hiyama T, Fujimoto I. Incidence of childhood cancer in Osaka, Japan, 1971–1988: reclassification of registered cases by Birch's scheme using information on clinical diagnosis, histology and primary site. Jpn. J. Cancer Res. 1994;85:136–146
  27. Macfarlane G, Evstifeeva T, Boyle P, Grufferman S. International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int. J. Cancer. 1995;61:165–169
  28. Kusuda M, Toriyama K, Kamidigo N, Itakura H. A comparison of epidemiologic, histologic, and virologic studies on Hodgkin's disease in western Kenya and Nagasaki, Japan. Am. J. Trop. Med. Hyg. 1998;59:801–807
  29. King H, Locke FB. Cancer mortality among Chinese in the United States. J. Natl. Cancer Inst. 1980;65:1141–1148
  30. Ho FC, Todd D, Loke SL, Ng RP, Khoo RK. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int. J. Cancer. 1984;34:143–148
  31. Liang R, Choi P, Todd D, Chan TK, Choy D, Ho F. Hodgkin's disease in Hong Kong Chinese. Hematol. Oncol. 1989;7:395–403
  32. Xiaolong J, Weihua L. Malignant lymphomas in Beijing. J. Environ. Pathol. Toxicol. Oncol. 1992;11:327–329
  33. Zhou X-G, Hamilton-Dutoit SJ, Yan Q-H, Pallesen G. The association between Epstein–Barr virus and Chinese Hodgkin's disease. Int. J. Cancer. 1993;55:359–363
  34. Paulino A, Paulino-Cabrera E, Weiss L, Medeiros L. Hodgkin's disease in the Philippines. Mod. Pathol. 1996;9:115–119
  35. Stiller C, McKinney P, Bunch K, Bailey C, Lewis I. Childhood cancer and ethnic group in Britain: a United Kingdom Children's Cancer Study Group (UKCCSG) study. Br. J. Cancer. 1991;64:543–548
  36. Parkes S, Coad N, Muir K, Jones T, Cameron A, Mann J. Hodgkin's disease in children in the west Midlands, 1957–1986: a large population-based study. Pediatr. Hematol. Oncol. 1994;11:471–486
  37. Powell JE, Parkes SE, Cameron AH, Mann JR. Is the risk of cancer increased in Asians living in the UK?. Arch. Dis. Child. 1994;71:398–403
  38. Nandakumar A, Anantha N, Venugopal T, Reddy S, Padmanabhan B, Swamy K, et al. Descriptive epidemiology of lymphoid and haemopoietic malignancies in Bangalore, India. Int. J. Cancer. 1995;63:37–42
  39. Varghese C, Barrett J, Johnston C, Shires M, Rider L, Forman D. High risk of lymphomas in children of Asian origin: ethnicity or confounding by socioeconomic status?. Br. J. Cancer. 1996;74:1503–1505
  40. Winter H, Cheng KK, Cummins C, Maric R, Silcocks P, Varghese C. Cancer incidence in the south Asian population of England (1990–1992). Br. J. Cancer. 1999;79:645–654
  41. Cozen W, Katz J, Mack TM. Risk patterns of Hodgkin's disease in Los Angeles vary by cell type. Cancer Epidemiol. Biomarkers Prev. 1992;1:261–268
  42. Peh S, Looi L, Pallesen G. Epstein–Barr virus (EBV) and Hodgkin's disease in a multi-ethnic population in Malaysia. Histopathologia. 1997;30:227–233
  43. Swerdlow AJ, Marmot MG, Grulich AE, Head J. Cancer mortality in Indian and British ethnic immigrants from the Indian subcontinent to England and Wales. Br. J. Cancer. 1995;72:1312–1319
  44. Talvalkar GV, Sampat MB, Gangadharan P. Hodgkin's disease in Western India: review of 1082 cases. Cancer. 1982;50:353–359
  45. Hartge P, Devesa S, Fraumeni JF Jr. Hodgkin's and non-Hodgkin's lymphomas. Cancer Surveys 1994;19–20:423–453.
  46. US Census Bureau. Census of Population and Housing, 1990: Subject Summary Tape File (SSTF) 5. The Asian and Pacific Islander Population in the United States. http://goldrush.berkeley.edu/GorData/info/SSTF5/
  47. Stiller C. What causes Hodgkin's disease in children?. Eur. J. Cancer. 1998;34:523–528
  48. Glaser SL, Swartz WG. Time trends in Hodgkin's disease incidence. The role of diagnostic accuracy. Cancer. 1990;66:2196–2204
  49. Browning MJ, McMichael AJ. HLA and MHC: Genes, Molecules and Function. Oxford: BIOS Scientific; 1996;
  50. Klitz W, Aldrich CL, Fildes N, Horning SJ, Begovich AB. Localization of predisposition to Hodgkin disease in the HLA class II region. Am. J. Hum. Genet. 1994;54:497–505
  51. Taylor GM, Gokhale DA, Crowther D, Woll PJ, Harris M, Ryder D, et al. Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes. Br. J. Cancer. 1999;80:1405–1411
  52. Oza AM, Tonks S, Lim J, Fleetwood MA, Lister TA, Bodmer JG. A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease. Cancer Res. 1994;54:5101–5105
  53. Bugawan TL, Chang JD, Klitz W, Erlich HA. PCR/oligonucleotide probe typing of HLA class II alleles in a Filipino population reveals an unusual distribution of HLA haplotypes. Am. J. Hum. Genet. 1994;54:331–340
  54. Glaser SL. Regional variation in Hodgkin's disease incidence by histologic subtype in the US. Cancer. 1987;60:2841–2847
  55. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, et al. Epstein–Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int. J. Cancer. 1997;70:375–382
  56. Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CN, McPhee SJ. Accuracy of racial classification of Vietnamese patients in a population-based cancer registry. Ethn. Dis. 1998;8:218–227
  57. Glaser SL, Clarke CA, Nugent RA, Dorfman RF, Stearns, CB. Social class and risk of Hodgkin's disease in young adult women in 1988–94. Int J Cancer 2001, under revision.

PII: S0145-2126(01)00126-6

Leukemia Research
Volume 26, Issue 3 , Pages 261-269 , March 2002

Article Tools

* Image Usage & Resolution